|
Feb 16
|
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript
|
|
Feb 16
|
Q4 2023 Corcept Therapeutics Inc Earnings Call
|
|
Feb 13
|
Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight
|
|
Feb 12
|
Teva Pharmaceutical upgraded at Piper Sandler
|
|
Jan 12
|
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
|
|
Jan 10
|
3 No-Brainer Stocks to Buy With $20 Right Now
|
|
Jan 2
|
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
|
|
Jan 2
|
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
|
|
Dec 29
|
Corcept loses patent spat against Teva, shares tumble
|
|
Dec 29
|
UPDATE 2-Corcept loses patent spat against Teva, shares tumble
|
|
Dec 28
|
Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 26
|
HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 Elections
|
|
Dec 21
|
Here’s Why Teva Pharmaceutical Industries Limited (TEVA) Rose in Q3
|
|
Dec 15
|
My 5 Largest Portfolio Holdings for 2024
|
|
Dec 14
|
Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma
|
|
Dec 7
|
FTC warns pharma companies on excessive drug patenting
|
|
Dec 6
|
New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity
|
|
Nov 30
|
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
|
|
Nov 27
|
Teva Pharmaceutical upgraded to 'Buy' at UBS
|
|
Nov 27
|
Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls
|